Cargando…

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors

SIMPLE SUMMARY: Minimal residual disease (MRD) represents a status of the disease which is assumed to still be present in the body until it is clinically observed by radiology. At this time point, the tumor relapse is present and a new clinical decision should be taken. However, there is currently n...

Descripción completa

Detalles Bibliográficos
Autores principales: Larribère, Lionel, Martens, Uwe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616165/
https://www.ncbi.nlm.nih.gov/pubmed/34830853
http://dx.doi.org/10.3390/cancers13225698